Login

From the Helm: Lindsay Partridge on Brickworks' Growth and Dividend Success | Lindsay Partridge - CEO of brickworks ltd 00:10:00

Share On Facebook Share On Twitter

Lindsay Partridge is the CEO of brickworks ltd

Recent Videos

00:10:00
Dryden Gold Secures $20M+ War Chest, Delivers High-Grade Discoveries and Expands Drill Targets Across Gold Rock District|Trey Wasser,CEO & Director,Dryden Gold
00:10:00
Mitchell Services Targets $50–60M EBITDA as Rig Utilization Drives Earnings Upside| Andrew Elf,CEO,Mitchell Services Limited
00:10:00
Lomiko Metals Reports Strong Pre-Feasibility Results with $800M NPV, Advancing High-Growth Graphite Projects|Gordana Slepcev,CEO,Lomiko Metals Inc.4
00:10:00
Generative AI Meets Wet Lab: Absci Accelerates Biologic Development with Hybrid Business Model|Sean McClain,CEO,Absci
00:10:00
Obliva Aims to Transform Lives of Children with Rare Mitochondrial Disorders|Ellen K. Donnelly ,CEO,Abliva AB7
00:10:00
Abionic Repositions Bio-HDL Therapy CCR001 for Rare Kidney and Eye Disorders with Promising Early Results|Cyrille Tupin,CEO,ABIONYX Pharma
00:10:00
Abingdon Health Reports 45% H1 Revenue Growth Amid Strategic Expansion and Large Contract Wins|Dr Chris Hand,Chairman,Abingdon Health
00:10:00
EB-101 Gene Therapy Shows Promising Results in Treating Recessive Dystrophic EB|Vishwas Seshadri,CEO,Abeona Therapeutics
00:10:00
Revolutionizing Trauma Care: How AAP’s Silver Technology is Fighting Deadly Implant Infections|Rubino Di Girolamo,CEO,aap Implantate AG
00:10:00
Revolutionizing Cancer Treatment: Tumor-Agnostic mTOR Targeting Shows Breakthrough Success in Rare and Genetic-Driven Tumors| Neil Desai, Founder, Executive Chairman ,Aadi Bioscience
00:10:00
Millions Affected, No Approved Cure: 89bio Advances New Therapy for NASH|Rohan Palekar,CEO,89bio Inc2
00:10:00
Malaria Prevention Drug Arakoda Positioned to Drive Future Growth for 60 Degrees Pharmaceuticals|Geoffrey Dow,President,60 Degrees Pharmaceuticals
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4basebio CEO Heikki Lanckriet Unveils Vision for Next-Generation Synthetic DNA and Gene Therapy Components|Heikki Lanckriet,CEO,4basebio
00:10:00
Jim Woody on Leading 180 Life Sciences: Advancing Breakthrough Biologic Therapies for Inflammation, Fibrosis, and Pain|Dr. Jim Woody,CEO,180 Life Sciences

Suggestions

00:10:00
Mazagon Dock Shipbuilders Hits Record High After Q4 & FY24 Earnings: 101% Profit Surge and Dividend Boost | Narayan Prasad, Chairman , Mazagon Dock Shipbuilders Ltd.
00:10:00
Presentation on Orca Gold's African Mining Ventures
00:10:00
Interview with Jean Paul Sosos, Interim CEO of Chesapeake Gold Corp.
00:10:00
Economic and Market Outlook for 2024: Insights from Russell Investments
00:10:00
Navigating Finances in Blended Families: Expert Advice from Walkner Condon Financial Advisors
00:10:00
Innovation knows no bounds and opportunity beckons with every launch|Dan Kimerling,Managing Partner, Deciens Capital
00:10:00
AeroVironment CEO discusses life-saving innovations on CNBC's Mad Money.
00:10:00
Maximizing Your Charitable Impact with Donor-Advised Funds | Rebecca Conner, Founder, SeedSafe Financial LLC.
00:10:00
Virmani, Punj, Frontline: The Cargojet Connection | Dr. Ajay K. Virmani - CEO of Cargojet
00:10:00
Companies That Transform: Alicorp Discusses Its Winning Initiative | Alfredo Perez Gubbins, CEO, ALi Corp3041:TAI
00:10:00
Embarking on a New Horizon: Rob Adams' Inaugural Address at Perpetual | Rob Adams, CEO , Perpetual Limited .
00:10:00
Revolutionizing Cancer Screening: A Breakthrough in Liquid Biopsy Technology Unveiled| Chris Yu, CEO, AnPac Bio-Medical Science Co Ltd.

© 2017 - Neuhu+